Determinants for symptomatic gallstone disease readmissions - results from a cohort with screen-detected gallstone

D M Shabanzadeh1, L T Sørensen2, T Jørgensen3

  • 1Digestive Disease Center, Bispebjerg University Hospital, Bispebjerg bakke 23, 2400 Copenhagen, Denmark; Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Nordre Fasanvej 57, 2000 Frederiksberg, Denmark.

Insights

Symptomatic gallstones lead to frequent readmissions and cholecystectomy. Epigastric pain, larger gallstones, and younger age predict readmission risk in gallstone disease patients.

Area of Science:

  • Gastroenterology
  • Surgical Outcomes
  • Epidemiology

Background:

  • Objective criteria for selecting patients for cholecystectomy are lacking.
  • Gallstone disease management is challenged by predicting patient outcomes.
  • Understanding readmission determinants is crucial for optimizing gallstone disease care.

Purpose of the Study:

  • To identify patient, symptom, and gallstone characteristics associated with hospital readmission.
  • To analyze factors influencing readmission in an unselected cohort with symptomatic, screen-detected gallstone disease.
  • To provide evidence for developing objective criteria for cholecystectomy selection.

Main Methods:

  • A cohort study utilizing data from three population-based cohorts.
  • Ultrasound screening identified 664 participants with gallstones; 84 had a first admission without cholecystectomy.
  • Age-adjusted Cox regression analyses were performed to assess readmission predictors.

Main Results:

  • Readmissions occurred in 60.8% of patients; 47.7% eventually underwent cholecystectomy.
  • Early readmissions were linked to epigastric pain (HR 3.63) of moderate intensity (HR 2.71).
  • Late readmissions were associated with larger gallstones (>10mm, HR 4.11) and younger age (HR 0.97).

Conclusions:

  • Symptomatic gallstone disease carries a high risk of future readmission and cholecystectomy.
  • Epigastric pain, larger gallstone size, and younger age are key determinants of readmission.
  • These factors should be incorporated into future clinical algorithms for gallstone disease management.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.0K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.3K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
513
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.1K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
914
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
475